2014 annual financial data

Tempest Therapeutics 2014 Net margin

Tempest Therapeutics 2014 net margin with verified reported values.

Direct answer

Net margin was -508.68%.

Operating income was -47,933,000 USD and net income was -49,520,000 USD.
Operating cash flow was -30,588,000 USD.

Get free Tempest Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
9,735,000 USD
Operating income
-47,933,000 USD
Net income
-49,520,000 USD
Operating cash flow
-30,588,000 USD